Abstract Endometrial cancer (EC) harboring heterozygous POLE proofreading inactivating mutations (POLE-exo*) is associated with an increased number of somatic mutations that result in a distinctive an
+Mutation nomenclature according to NM_000249.3 (MLH1), NM_000251.2 (MSH2) and NM_000179.2 (MSH6). For the nomenclature of mutations nucleotide 1 is the A of the ATG-translation initiation codon. ++Cl
Major cause of mortality in ovarian cancer can be attributed to a lack of specific and sensitive biomarkers for diagnosis and prognosis of the disease. Uncovering the mutations in genes involved in cr
